HA
JAZZ icon

Herold Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Herold Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25
Closed -$3.89K – 424
2022
Q1 		$3.89K Buy
+25
New +$3.63K ﹤0.01% 685
2021
Q4 		– Sell
-25
Closed -$3K – 412
2021
Q3 		$3K Buy
+25
New +$3.78K ﹤0.01% 686

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Herold Advisors's JAZZ Position: Q2 2022 in Review

Herold Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 25 shares — an estimated $3.89K sold.

Herold Advisors first reported a position in JAZZ in Q3 2021 and held it in 2 quarters. The position peaked at $3.89K in Q1 2022. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Herold Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Herold Advisors sold 25 Jazz Pharmaceuticals shares in Q2 2022, an estimated $3.89K.
  • Herold Advisors first reported a position in Jazz Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Herold Advisors's Jazz Pharmaceuticals position peaked at $3.89K in Q1 2022.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Herold Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.